Targeting Gene Regulators of Cardiomyocyte Dysfunction: A New RNAi Paradigm for Heart Failure
10:00 am - Wednesday 28th January 2026
- Leveraging highly specific RNAi therapeutics, directly silencing key myocardial genes, to halt the underlying disease progression and move beyond symptom management
- Utilizing a novel, targeted delivery platform, enabling efficient extrahepatic delivery to cardiac tissue, to achieve robust efficacy and open new treatment possibilities for patients
- Addressing the root cause of cardiomyocyte disfunction to restore cardiac function and significantly improve patient quality of life
